Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Circ Heart Fail. 2013 Apr 26;6(4):669–675. doi: 10.1161/CIRCHEARTFAILURE.112.000291

Table 1.

Baseline Participant Characteristics by Self-Reported Physical Functioning

Overall (N=352) Low (N=50) Moderate-High (N=302) P-value
Age at heart failure onset (years) 76 (65-83) 76 (66-84) 76 (64-83) 0.52
Male 209 (59.4) 23 (46.0) 186 (61.6) 0.04
Body mass index (kg/m2) 29.9 (26.2-34.8) 31.1 (27.8-36.4) 29.7 (26.0-34.5) 0.12
Current smoking status 28 (8.0) 3 (6.0) 25 (8.3) 0.78
Married 215 (61.1) 27 (54.0) 188 (62.3) 0.27
>High school education 164 (48.0) 18 (37.5) 146 (50.0) 0.18
Charlson comorbidity index 3 (2-5) 5 (3-7) 3 (2-5) <0.001
Estimated glomerular filtration rate (mL/min per 1.73 m2) 57.8 (22.7) 54.5 (27.2) 58.3 (21.9) 0.30
Serum sodium (mmol/L) 140 (138-142) 140 (138-142.6) 140 (138-142) 0.61
Hyperlipidemia 285 (81.0) 41 (82.0) 244 (80.8) 0.84
Hypertension 318 (90.3) 48 (96.0) 270 (89.4) 0.20
Diabetes 132 (37.5) 24 (48.0) 108 (35.9) 0.10
Myocardial infarction 92 (26.1) 17 (34.0) 75 (24.8) 0.17
Chronic obstructive pulmonary disease 90 (25.6) 19 (38.0) 71 (23.5) 0.03
Depression 135 (38.4) 26 (52.0) 109 (36.1) 0.03
Ejection fraction <50% 192 (54.5) 23 (46.0) 169 (56.0) 0.19
Prevalent heart failure 199 (56.5) 34 (68.0) 165 (54.6) 0.08
Beta blockers 293 (83.2) 43 (86.0) 250 (82.8) 0.57
Angiotensin converting enzyme inhibitors/angiotensin II receptor blockers 240 (68.2) 31 (62.0) 209 (69.2) 0.31
Statins 206 (58.5) 29 (58.0) 177 (58.6) 0.94

Values are mean (SD) or median (25th, 75th percentile) for continuous variables and N (%) for categorical variables.